- Home
- LRHC vs TOVX Comparison
LRHC vs TOVX Comparison
Compare LRHC & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- TOVX
- Stock Information
- Founded
- LRHC 2004
- TOVX 2001
- Country
- LRHC United States
- TOVX United States
- Employees
- LRHC N/A
- TOVX N/A
- Industry
- LRHC
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- TOVX Health Care
- Exchange
- LRHC Nasdaq
- TOVX Nasdaq
- Market Cap
- LRHC 5.4M
- TOVX 4.5M
- IPO Year
- LRHC 2023
- TOVX 2006
- Fundamental
- Price
- LRHC $7.87
- TOVX $0.41
- Analyst Decision
- LRHC
- TOVX Hold
- Analyst Count
- LRHC 0
- TOVX 1
- Target Price
- LRHC N/A
- TOVX N/A
- AVG Volume (30 Days)
- LRHC 48.1K
- TOVX 359.6K
- Earning Date
- LRHC 08-18-2025
- TOVX 11-11-2025
- Dividend Yield
- LRHC N/A
- TOVX N/A
- EPS Growth
- LRHC N/A
- TOVX N/A
- EPS
- LRHC N/A
- TOVX N/A
- Revenue
- LRHC $78,037,079.00
- TOVX N/A
- Revenue This Year
- LRHC N/A
- TOVX N/A
- Revenue Next Year
- LRHC N/A
- TOVX N/A
- P/E Ratio
- LRHC N/A
- TOVX N/A
- Revenue Growth
- LRHC 54.92
- TOVX N/A
- 52 Week Low
- LRHC $4.33
- TOVX $0.37
- 52 Week High
- LRHC $142.40
- TOVX $4.20
- Technical
- Relative Strength Index (RSI)
- LRHC 58.69
- TOVX 46.77
- Support Level
- LRHC $6.86
- TOVX $0.38
- Resistance Level
- LRHC $9.72
- TOVX $0.45
- Average True Range (ATR)
- LRHC 0.81
- TOVX 0.02
- MACD
- LRHC 0.21
- TOVX 0.00
- Stochastic Oscillator
- LRHC 56.26
- TOVX 44.86
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.